ALBI versus child-pugh in predicting outcome of patients with HCC: A systematic review

Ying Peng1,2, Qinglin Wei1,2, Yonghong He1,2

  • 1Cholestatic Liver Diseases Center and Department of Gastroenterology, Southwest Hospital, Third Military Medical University (Army Medical University) , Chongqing, China.

Insights

The albumin-bilirubin (ALBI) score demonstrates superior ability in predicting outcomes for hepatocellular carcinoma (HCC) patients compared to the Child-Pugh score. Further research is needed to enhance prognostic accuracy for HCC.

Area of Science:

  • Hepatology
  • Oncology
  • Biomarker Research

Background:

  • Hepatocellular carcinoma (HCC) is a highly aggressive cancer with a poor patient prognosis.
  • The albumin-bilirubin (ALBI) score and Child-Pugh score are established tools for assessing prognosis in liver disease patients.
  • Comparing the prognostic predictive power of ALBI and Child-Pugh scores in HCC is crucial for clinical decision-making.

Purpose of the Study:

  • To systematically review and compare the prognostic discriminative ability of the ALBI score versus the Child-Pugh score in patients with hepatocellular carcinoma.
  • To evaluate the current effectiveness of these scoring systems in predicting HCC patient outcomes.

Main Methods:

  • A systematic literature search was conducted across major databases: PubMed, EMBASE, and Cochrane Library.
  • Relevant studies comparing the prognostic abilities of ALBI and Child-Pugh scores in HCC patients were identified and data extracted.
  • The extracted data were analyzed to assess the comparative predictive performance of the two scoring systems.

Main Results:

  • The systematic review indicated that the ALBI score possesses superior discriminative ability compared to the Child-Pugh score for predicting prognosis in HCC patients.
  • Despite ALBI's better performance, the overall predictive accuracy of both scores requires improvement for clinical utility.
  • The study highlights the need for more refined prognostic indicators in HCC management.

Conclusions:

  • The ALBI score is a more effective prognostic predictor than the Child-Pugh score in hepatocellular carcinoma.
  • Advanced genomic and molecular techniques, such as sequencing and methylation analysis, offer potential for discovering novel HCC biomarkers.
  • Future research should focus on validating new prognostic tools through multicenter prospective studies for early diagnosis and improved prognosis of HCC.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
123
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
491
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
335
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
158